<DOC>
	<DOC>NCT02321475</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness of EGb 761® (Tanakan®) in Russian patients of middle age and younger, suffering from psycho-emotional symptoms added to cognitive disorders based on the improvement of FAM test (feeling-healthy, activity, mood test) score.</brief_summary>
	<brief_title>EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Patients who signed the Informed Consent for participation in the observational study before collection of any information Patients who complain of psychoemotional disturbance (of any intensity) Men and women aged 1845 years, who prescribed to receive Tanakan® for cognitive disorders Presence of any contraindications listed in the Tanakan® local SmPC (hypersensitivity to any of the components of Tanakan®, pregnancy, lactation, erosive gastritis in acute phase, gastric ulcer and duodenum ulcer in acute phase, acute cerebrovascular accident, acute myocardial infarction, congenital galactosemia, lactase deficiency, glucosegalactose malabsorption, haemolysis) Presence of dementia (according to Diagnostic and Statistical Manual of Mental Disorders [DSM IV]) Disturbance of usual activities of daily living (e.g. selfcare) Patients taking antipsychotic drugs, antidepressants, tranquillisers and nootropic agents Presence of any severe disease or condition which could affect cognitive function (e.g. Parkinson disease, epilepsy, brain inflammatory disease, major depression, recent poststroke condition, recent braintrauma etc.); Presence of anxiety or depression according to the Hospital Anxiety and Depression Scale (11 points and more).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Psycho-emotional symptoms</keyword>
</DOC>